← Leaderboards
Olivia Skye Montoya
University Of Miami School Of Medicine
$94,446
Attributed
$94,446
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2022–23$50K$37.5K$25K$12.5K$0
'22
'23
Funding mix
By agency
NIH$94,446 · 1
By mechanism
F31$94,446 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Nouri Neamati$15,871,783
- Badri N Vardarajan$28,901,449
- David Benner Lombard$7,065,267
- Caroline Alice Coughlin$209,456
- Fangliang Zhang$3,244,454
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignAffinityCombined Modality TherapyConsensusAlternative TherapiesAlternative TreatmentAftercareAdultB-Cell Antigen ReceptorAgammaglobulinaemia Tyrosine KinaseB-Cell NeoplasmBcl2 GeneBindingBinding SitesBiochemicalB Lymphoid MalignancyCell LineCellsCell TherapyChemotherapyChronic Lymphocytic LeukemiaB-Cell LymphomasClinical TrialsDisease Remission
Grant awards (2)
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies$47,694
F31 · FY2023 · CA · contact PI
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies$46,752
F31 · FY2022 · CA · contact PI